These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17496539)

  • 1. CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation.
    Pearl JP; Xu H; Leopardi F; Preston E; Kirk AD
    Transplantation; 2007 May; 83(9):1219-25. PubMed ID: 17496539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
    Preston EH; Xu H; Dhanireddy KK; Pearl JP; Leopardi FV; Starost MF; Hale DA; Kirk AD
    Am J Transplant; 2005 May; 5(5):1032-41. PubMed ID: 15816883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
    Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
    Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
    Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation.
    Xu H; Montgomery SP; Preston EH; Tadaki DK; Hale DA; Harlan DM; Kirk AD
    J Immunol; 2003 Mar; 170(5):2776-82. PubMed ID: 12594309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloimmunity in primate heart recipients with CD154 blockade: evidence for alternative costimulation mechanisms.
    Azimzadeh AM; Pfeiffer S; Wu G; Schröder C; Zorn GL; Kelishadi SS; Ozkaynak E; Kehry M; Atkinson JB; Miller GG; Pierson RN
    Transplantation; 2006 Jan; 81(2):255-64. PubMed ID: 16436970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
    Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
    Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.
    Kirk AD; Burkly LC; Batty DS; Baumgartner RE; Berning JD; Buchanan K; Fechner JH; Germond RL; Kampen RL; Patterson NB; Swanson SJ; Tadaki DK; TenHoor CN; White L; Knechtle SJ; Harlan DM
    Nat Med; 1999 Jun; 5(6):686-93. PubMed ID: 10371508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates.
    Kim JS; Lee JI; Shin JY; Kim SY; Shin JS; Lim JH; Cho HS; Yoon IH; Kim KH; Kim SJ; Park CG
    Transplantation; 2009 Dec; 88(12):1349-59. PubMed ID: 20029331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?
    Koulmanda M; Smith RN; Qipo A; Weir G; Auchincloss H; Strom TB
    Am J Transplant; 2006 Apr; 6(4):687-96. PubMed ID: 16539625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.
    Ferrer IR; Wagener ME; Song M; Ford ML
    PLoS One; 2012; 7(7):e40559. PubMed ID: 22792369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective CD28 Inhibition Modulates Alloimmunity and Cardiac Allograft Vasculopathy in Anti-CD154-Treated Monkeys.
    Zhang T; Azimzadeh AM; Sun W; O'Neill NA; Sievert E; Bergbower E; Braileanu G; Burdorf L; Cheng X; Monahan T; Dahi S; Harris DG; Rybak E; Welty E; Kronfli A; Avon C; Pierson RN
    Transplantation; 2018 Mar; 102(3):e90-e100. PubMed ID: 29319621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
    Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
    Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
    Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
    Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.
    Lo DJ; Anderson DJ; Weaver TA; Leopardi F; Song M; Farris AB; Strobert EA; Jenkins J; Turgeon NA; Mehta AK; Larsen CP; Kirk AD
    Am J Transplant; 2013 Feb; 13(2):320-8. PubMed ID: 23311611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance.
    Chalermskulrat W; McKinnon KP; Brickey WJ; Neuringer IP; Park RC; Sterka DG; Long BR; McNeillie P; Noelle RJ; Ting JP; Aris RM
    Thorax; 2006 Jan; 61(1):61-7. PubMed ID: 16254057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys.
    Azimzadeh AM; Zhang T; Wu G; Kelishadi SS; Stoddard T; OʼNeill N; Nguyen BN; Welty E; Avon C; Higuchi M; Mitchell SL; Hershfeld A; Cheng XF; Kronfli A; Rybak E; Burdorf L; Pierson RN
    Transplantation; 2017 Jan; 101(1):63-73. PubMed ID: 27362307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
    Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
    Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.